Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Hyperglycemia, Postprandial

17-alpha-hydroxyprogesterone has been researched along with Hyperglycemia, Postprandial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Y; Hu, C; Jiang, J; Li, X; Liu, B; Lu, Y; Lu, Z; Qian, Y; Wang, E; Wu, D; Xiang, L; Xiong, X; Yan, J; Zhang, H; Zhang, R; Zhao, J; Zhao, L; Zhou, B1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Hyperglycemia, Postprandial

ArticleYear
Obesity-induced excess of 17-hydroxyprogesterone promotes hyperglycemia through activation of glucocorticoid receptor.
    The Journal of clinical investigation, 2020, 07-01, Volume: 130, Issue:7

    Topics: 17-alpha-Hydroxyprogesterone; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Liver; Male; Mice; Obesity; Receptors, Glucocorticoid; Signal Transduction; Steroid 17-alpha-Hydroxylase

2020